0001493152-23-001331.txt : 20230112
0001493152-23-001331.hdr.sgml : 20230112
20230112190024
ACCESSION NUMBER: 0001493152-23-001331
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221114
FILED AS OF DATE: 20230112
DATE AS OF CHANGE: 20230112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gates Erica F.
CENTRAL INDEX KEY: 0001885958
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40943
FILM NUMBER: 23526869
MAIL ADDRESS:
STREET 1: C/O BIOFONTERA INC.,
STREET 2: 120 PRESIDENTIAL WAY, SUITE 330
CITY: WOBURN
STATE: MA
ZIP: 01801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biofrontera Inc.
CENTRAL INDEX KEY: 0001858685
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473765675
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 120 PRESIDENTIAL WAY,
STREET 2: SUITE 330
CITY: WOBURN
STATE: MA
ZIP: 01801
BUSINESS PHONE: 781-245-1325
MAIL ADDRESS:
STREET 1: 120 PRESIDENTIAL WAY,
STREET 2: SUITE 330
CITY: WOBURN
STATE: MA
ZIP: 01801
4
1
ownership.xml
X0306
4
2022-11-14
1
0001858685
Biofrontera Inc.
BFRI
0001885958
Gates Erica F.
120 PRESIDENTIAL WAY
SUITE 330
WOBURN
MA
01801
0
1
0
0
Senior Director Finance
Following the appointment of Fred Leffler as Chief Financial Officer, the reporting person no longer serves as the principal accounting officer of the Company and the reporting person's policy making functions have changed such that she is no longer considered an "officer" for purposes of Section 16. The reporting person will continue in her role as Senior Director Finance, but will no longer be required to report transactions in equity securities of the registrant on Form 4 or Form 5.
/s/ Daniel Hakansson, Attorney-in-fact for Erica F. Gates
2023-01-12